Investment Management

Innovative products and solutions across the liquidity spectrum

Digital Health

The convergence of technology, retail and health care

Biotech

The leading voice in life sciences

E-Commerce

Insights into the world’s most dynamic companies

Featured News

Corporate Access & Conferences

Connecting companies with the investment community

John Blackledge recaps Cowen's call w/ad agency that runs >$500M in digital ads for 200+ clients. Clients' spend on $GOOG was +18% y/y

Biotech

Ahead of the Curve

Jun 30 2017

Biotech – Cowen Analysis: When Insiders Buy, Investors Should Too

Cowen analyzed 4K+ open market transactions made by insiders at the 10 largest biotechnology companies over the last 10 years. We find that purchases by insiders are a strong predictor of outperformance, while stock sales by insiders have little predictive value. When insiders purchase shares of fundamentally strong companies, a successful strategy would seem to be to buy right along with them.
Featured Profile
“The sell side is high energy and I love the 'work hard/play hard' culture.”
Jean Perreault, Vice President, Research
Featured Profile
“Day to day, I work with all of the business groups and teams within Cowen, either directly or behind the scenes.”
Peggy Finster, Managing Director, Labor and Employment Counsel
Featured Profile
“We worked on the Trivago IPO, the Facebook IPO, the sale of Living Social to Groupon and the Wayfair IPO.”
Jose A. Cobos, Managing Director, Technology, Media and Telecom
Featured Profile
“We've built a large, generalist platform that gives me an opportunity to interact with more clients.”
David Rountree, Managing Director, Equity Sales